 |
|
| Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
|
|
Thread Tools | Display Modes |
02-24-2011, 08:51 AM
|
#1 | ||
|
|||
|
Member
|
Abstract available only.
Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease Clinical trials involving direct infusion of neurotrophic therapies for Parkinson's disease (PD) have suffered from poor coverage of the putamen. The planned use of a novel interventional-magnetic resonance imaging (iMRI) targeting system for achieving precise, real-time convection-enhanced delivery in a planned clinical trial of adeno-associated virus serotype 2 (AAV2)-glial-derived neurotrophic factor (GDNF) in PD patients was modeled in nonhuman primates (NHP). Prior GDNF - full history fingers_crossed.jpg |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | lou_lou (03-10-2011) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| gdnf...it's back? | Parkinson's Disease | |||
| The return of gdnf | Parkinson's Disease | |||
| Gdnf | Parkinson's Disease | |||
| The GDNF fiasco | Parkinson's Disease | |||
| GDNF Book | Parkinson's Disease | |||
Aav2-gdnf
Threaded Mode